Difficulty: Medium
Average Score: 70%
Practice
Which mutated tumor suppressor gene is most likely to contribute to many types of cancer, including bladder, breast, colorectal, and lung?
Correct answer
A
Rationale
In the context of pharmacology, understanding the role of tumor suppressor genes in cancer development is crucial. In this question, the correct answer is A) p53. The p53 gene is known as the "guardian of the genome" because it plays a critical role in preventing cancer by regulating cell division and promoting cell death when necessary. Mutations in the p53 gene can lead to uncontrolled cell growth and are associated with various types of cancer, including bladder, breast, colorectal, and lung cancers.
Option B) APC is a tumor suppressor gene commonly associated with colorectal cancer, particularly in cases of familial adenomatous polyposis (FAP). Mutations in the APC gene predispose individuals to the development of numerous polyps in the colon, increasing the risk of cancer.
Options C) BRCA1 and D) BRCA2 are known as breast cancer susceptibility genes. Mutations in these genes significantly increase the risk of developing breast and ovarian cancers, especially in individuals with a family history of these cancers. While BRCA1 and BRCA2 mutations are not typically associated with the types of cancers listed in the question (bladder, colorectal, lung), they are important in the context of hereditary breast and ovarian cancer syndrome.
Educationally, this question highlights the importance of understanding specific tumor suppressor genes and their implications in different types of cancer. It reinforces the significance of genetic factors in cancer development and underscores the diverse roles of various genes in maintaining cellular homeostasis. Understanding these concepts is vital for pharmacology students to comprehend the molecular basis of cancer and design targeted therapies that can exploit these genetic vulnerabilities.
Option B) APC is a tumor suppressor gene commonly associated with colorectal cancer, particularly in cases of familial adenomatous polyposis (FAP). Mutations in the APC gene predispose individuals to the development of numerous polyps in the colon, increasing the risk of cancer.
Options C) BRCA1 and D) BRCA2 are known as breast cancer susceptibility genes. Mutations in these genes significantly increase the risk of developing breast and ovarian cancers, especially in individuals with a family history of these cancers. While BRCA1 and BRCA2 mutations are not typically associated with the types of cancers listed in the question (bladder, colorectal, lung), they are important in the context of hereditary breast and ovarian cancer syndrome.
Educationally, this question highlights the importance of understanding specific tumor suppressor genes and their implications in different types of cancer. It reinforces the significance of genetic factors in cancer development and underscores the diverse roles of various genes in maintaining cellular homeostasis. Understanding these concepts is vital for pharmacology students to comprehend the molecular basis of cancer and design targeted therapies that can exploit these genetic vulnerabilities.